Clinical Trials Logo

Filter by:
NCT ID: NCT01822704 Recruiting - Stroke Clinical Trials

Whole Body Vibration in Chronic Stroke

Start date: March 2013
Phase: N/A
Study type: Interventional

This study is a randomized controlled trial aimed to assess the efficacy of a 10-week whole body vibration training program on physical functioning, societal participation and quality of life in individuals with chronic stroke. It is hypothesized that the whole body vibration program will induce significantly more gain in physical functioning, societal participation, and quality of life in chronic stroke patients, compared with the control group.

NCT ID: NCT01810913 Recruiting - Clinical trials for Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Start date: March 22, 2013
Phase: Phase 2/Phase 3
Study type: Interventional

This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.

NCT ID: NCT01796145 Recruiting - Clinical trials for Confirmed Diagnosis of Hepatocellular Carcinoma

Fibroscan Study in HCC

Start date: February 27, 2013
Phase: N/A
Study type: Interventional

In patients with HCC undergoing therapy 1. We aim to determine the prognostic significance of liver stiffness in patients with HCC 2. We aim to determine the rate and severity of complications of treatment and its association with liver stiffness in patients with HCC

NCT ID: NCT01735682 Recruiting - Geriatric Disorder Clinical Trials

Whole Body Vibration Exercise Training for Institutionalized Elderly

Start date: November 2012
Phase: N/A
Study type: Interventional

It is hypothesized that whole body vibration exercise group will have significantly more improvement in physical functioning and reduction in fall incidence among institutionalized elderly, compared with conventional exercise group and control group.

NCT ID: NCT01734083 Recruiting - Dementia Clinical Trials

Whole Body Vibration Exercise for Elderly With Cognitive Impairments

Start date: November 2012
Phase: N/A
Study type: Interventional

The whole body vibration exercise group will have significantly more improvement in mobility, muscle strength, balance, balance confidence, and cognitive function with a lower fall rate than the control group.

NCT ID: NCT01690208 Recruiting - Obesity Clinical Trials

Evaluation of Morbidities, Endpoints and Reaching Targets in Diabetic Patients Managed by a Diabetes Specialist Team

EMERALD
Start date: May 2012
Phase: N/A
Study type: Interventional

This is a pilot translational study aiming to compare the effects of a multi-component care program with personalized drug regimen augmented by behavioural therapy with psychological support and peer influence, led by a diabetes specialist team on metabolic control, psychological health and behaviours in difficult-to-treat type 2 diabetic patients versus usual care. The study hypothesis is to evaluate a novel individualized, multicomponent care program to optimize glycemic control in difficult-to-treat type 2 diabetic patients.

NCT ID: NCT01673932 Recruiting - Stroke Clinical Trials

Safety and Feasibility Study of Umbilical Cord Blood Mononuclear Cells Transplant to Treat Ischemic Stroke

Start date: October 2012
Phase: Phase 1
Study type: Interventional

The study is to assess the safety and possible efficacy of umbilical cord blood mononuclear cells (UCBMC) treatment of chronic ischemic stroke.

NCT ID: NCT01593098 Recruiting - Adenoma Clinical Trials

A Prospective Study Into the Risk of Colorectal Neoplasms in Individuals With a Family History of Advanced Adenomas (Sibling AN Study)

AN
Start date: June 8, 2010
Phase:
Study type: Observational

To prospectively determine the prevalence of colorectal neoplasia in siblings of Hong Kong Chinese patients with advanced neoplasm compared with a sex and age-matched control population. To determine the molecular alteration profiles of colonic adenomas in siblings of patients with advanced neoplasm

NCT ID: NCT01581723 Recruiting - Clinical trials for Urinary Bladder Tumor

Clinical Trial Using Bipolar Technology for Transurethral Resection of Bladder Tumor

Start date: May 2012
Phase: Phase 3
Study type: Interventional

Bladder cancer is a common urological malignant disease. Patients with bladder cancer will first be managed with transurethral resection (TUR) of bladder tumor. For many years, monopolar transurethral resection of bladder tumor (TURP) has been the gold standard for treatment. However, complications including bleeding, bladder perforation and inadequate sampling of deep tumor biopsy remain the major concerns. Recently published papers suggested that the newer bipolar TUR technology has similar surgical outcomes but less complications comparing with monopolar TUR. In this study, investigators will investigate the benefit of new technology as compared with conventional monopolar resection on tumor clearance, complication and recurrence rates.

NCT ID: NCT01524471 Recruiting - Achalasia Clinical Trials

Per-Oral Endoscopic Myotomy (P.O.E.M.) for Treatment of Primary Esophageal Motility Disorders

Start date: July 2010
Phase: Phase 2
Study type: Interventional

Spastic esophageal motility disorders induced significant symptoms including dysphagia, retrosternal pain and regurgitation. Per oral endoscopic myotomy (P.O.E.M.) is a novel approach to perform myotomy through the esophagus with long submucosal tunnel. This study aimed to investigate the feasibility and safety of P.O.E.M. and translate the techniques from animal study to clinical practice in human.